119 results
8-K
EX-99.1
COGT
Cogent Biosciences Inc
7 May 24
Cogent Biosciences Reports First Quarter 2024 Financial Results
8:19am
release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited
8-K
EX-99.1
68vikdog
26 Feb 24
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
8:30am
8-K
EX-10.1
sx3tm
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-3.1
3er0azsqb
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-99.1
392b0s
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
7e043
11 Dec 23
Other Events
8:04am
8-K
EX-99.1
ycvm2p07ow0h yg
2 Nov 23
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2023 Financial Results
9:18am
8-K
EX-99.1
gykg9r 8q7qrxcpo8
8 Aug 23
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial Results
8:14am
8-K
EX-1.1
cy8phmsw24b7nc wa
8 Jun 23
Entry into a Material Definitive Agreement
4:31pm
8-K
djx1onhv h3q3l547b
6 Jun 23
Other Events
4:03pm